USPTO, DOJ Downplay Essential Patents' Licensing Terms

Law360 (February 7, 2020, 4:42 PM EST) -- After withdrawing support from a 2013 policy statement[1] on appropriate remedies for standard-essential patents subject to a commitment to license on fair, reasonable and nondiscriminatory terms, the U.S. Department of Justice's Antitrust Division and the U.S. Patent and Trademark Office, along with the National Institute of Standards and Technology, recently issued a new policy statement[2] on the same subject. 

The new statement emphasizes that, while the existence of a FRAND commitment is a "relevant factor" in determining appropriate remedies for infringement of SEPs, there is no “special set of legal rules” when it comes to FRAND-encumbered SEPs. Under this framework, all...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!